#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Vulval cancer Aicardi-Goutieres syndrome Behcet's syndrome Chondrodystrophy Alveolar proteinosis Adenocarcinoma gastric Congenital nephrogenic diabetes insipidus Red blood cell abnormality Thalassaemia alpha Facioscapulohumeral muscular dystrophy Drug eruption IPEX syndrome Neuronal ceroid lipofuscinosis PIK3CA-activated mutation Small cell lung cancer limited stage More trials…

    Learn about Rare Diseases

    Hereditary motor and sensory neuropathy – Diagnostics Osteosarcoma recurrent – Diagnostics Brain stem glioma Systemic sclerosis pulmonary Alagille syndrome – Diagnostics Biotinidase deficiency Small intestine leiomyosarcoma – Basic Information Sarcoma – Diagnostics Lysosomal storage disorder – Diagnostics Hairy cell leukaemia – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Elritercept Efmoroctocog Alfa HSP-CAR30 Vosilasarm Blu-222 Bi 1015550 Ttf-Ngr Calcium Carbonate Timrepigene Emparvovec Pelareorep Phosphocreatine Sodium Crizotinib Balcinrenone Sucrose Epcoritamab Gilteritinib Morf-057 Tramadol Dl-Alpha-Tocopherol F125/10 More therapies…

    Learn about Your Condition

    Diffuse large B-cell lymphoma Leukocyte adhesion deficiency Pancreatitis acute Microvillous inclusion disease Rectal cancer stage III Behavioural addiction Cough B-cell lymphoma recurrent Ependymoma Drug use disorder Krabbe's disease Colorectal cancer stage IV Cystic fibrosis Pyoderma Deafness traumatic More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Colorectal cancer

  • Study on the Safety and Effects of GSK4418959 and Dostarlimab for Adults with Colorectal Cancer with Mismatch Repair Deficiency or High Microsatellite Instability

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    • Neoplasm
    Investigated Drugs:
    • GSK4418959A
    • Dostarlimab
    Belgium The Netherlands Spain

  • Study on the Safety and Effectiveness of AZD0022 Alone and with Other Cancer Drugs for Adults with KRAS-G12D Mutated Tumors in Lung, Colorectal, and Pancreatic Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Adenocarcinoma pancreas
    • Colorectal cancer
    • Non-small cell lung cancer
    Investigated Drugs:
    • AZD0022
    • Cetuximab
    Belgium Italy The Netherlands Poland Spain

  • Study on Methadone Hydrochloride and Drug Combination for Patients with Advanced Metastatic Colorectal Cancer

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Neoplasm malignant
    • Colorectal cancer
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Methadone Hydrochloride
    • Fluorouracil
    • Folinic Acid
    Germany

  • Study on Mesalamine to Prevent Colorectal Cancer in Patients with Lynch Syndrome

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Hereditary non-polyposis colorectal cancer syndrome
    • Colorectal cancer
    Investigated Drugs:
    • Mesalazine
    Denmark Sweden

  • Study of Encorafenib, Cetuximab, and Pembrolizumab for Patients with Untreated BRAF V600E-Mutant Metastatic Colorectal Cancer

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Encorafenib
    • Cetuximab
    • Pembrolizumab
    Belgium Czechia Denmark France Germany Italy +6

  • Study on Reduced Dose Intensity of Pembrolizumab and Drug Combination for Patients with Advanced or Metastatic Cancer Responding to Standard Immunotherapy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Lung neoplasm malignant
    • Malignant melanoma
    • Oesophageal squamous cell carcinoma
    Investigated Drugs:
    • Avelumab
    • Dostarlimab
    • Atezolizumab
    France
Previous Page
1 … 9 10 11 12 13 … 15
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!